India’s first mRNA vaccine against Covid-19 from Gennova gets DCGI approval
Gennova's vaccine will be available for adults above 18 years of age. It will be a two-dose vaccine that will be administered intramuscularly at 28 days apart
zycov d
June 2022
April 2022
Covaxin, Corbevax get 'emergency use' nod for kids aged 5-12
The CDSCO approval has also been granted for two doses of ZyCov-D for those aged over 12. The decision comes amid a rise in Covid cases in cities like Delhi.
